Company news

Correvio Pharma Corp news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Cardiome Reports Third Quarter 2013 Financial Results

November 6, 2013

Cardiome Announces Presentation at Medical Conference and Provides Update on Journal Publications for Vernakalant

October 28, 2013

Cardiome To Hold Third Quarter 2013 Financial Results Conference Call On November 6

October 24, 2013

Cardiome Enters Commercialization Agreement With Algorithm S.A.L. For BRINAVESS(TM) In Middle East And North Africa

October 21, 2013

Cardiome Announces Commercialization Agreement With Biospifar S.A. For BRINAVESS(TM) In Colombia

October 9, 2013

Cardiome Announces Publication of Positive Data from an Observational, Retrospective Study of BRINAVESS

October 7, 2013

Cardiome Receives Approval For BRINAVESS(TM) In South Africa

September 30, 2013

Cardiome Receives Approval For BRINAVESS(TM) In Turkey

September 25, 2013

Cardiome Announces Commercialization Partnership with LifePharma (Z.A.M) Ltd. for BRINAVESS(TM) in Cyprus

September 24, 2013

Cardiome Announces Publication Of Positive Data From A Study Comparing Vernakalant IV Versus Propafenone And Flecainide

September 23, 2013

Cardiome Announces Commercialization Agreement With Tzamal Medical Group For Brinavess(TM) In Israel

September 17, 2013

Cardiome Completes Transfer Of Commercialization Responsibility For Brinavess(TM) In The EU

September 16, 2013

Cardiome Announces Its Presence At The ESC Congress 2013 In Amsterdam

August 29, 2013

Cardiome Reports Second Quarter 2013 Financial Results

August 2, 2013

Cardiome to Hold Second Quarter 2013 Financial Results Conference Call on August 2

July 19, 2013

Cardiome Announces Commercialization Partnership For BRINAVESS(TM) In Select European Markets

July 3, 2013

Cardiome Announces the Transfer of European Marketing Authorization from Merck

June 27, 2013

Cardiome Adopts Advance Notice Policy

May 28, 2013

Cardiome Reports First Quarter Results

May 13, 2013

Cardiome To Present At Bloom Burton & Co. Healthcare Investor Conference

May 10, 2013

Cardiome to Hold First Quarter 2013 Financial Results Conference Call on May 13

May 9, 2013

Cardiome Accepts the Transfer of Sponsorship of U.S. and Canadian Vernakalant IV and Oral Regulatory Filings from Merck

May 2, 2013

← Newer news releases

Decks